MENU
NVO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Novo-Nordisk A/S (NVO) Ownership - Who owns Novo-Nordisk A/S?

Profile

Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
366.23B
P/E Ratio
26.22
Total Cash
26.31B
Projected Growth
1.20
Total Debt
102.79B
Revenue
290.4B
Risk (Beta)
0.42
Dividend Yield
0.02
Total Cash/Share
5.93
Total Debt/Equity
2.39
Revenue/Share
9.15 USD as % of share price

Fundamentals

NVO
Capitalization
366B
P/E Ratio
26.22
Risk (Beta)
0.42
Dividend Yield
0.02
Total Cash
26.3B
Total Cash/Share
5.93
Total Debt
103B
Total Debt/Equity
2.39
Projected Growth (PEG Ratio)
1.20
Revenue/Share (as % of the share price)
9.15%
Revenue
290B
ROE
N/A
Book Value
143B
P/B Ratio
18.35
Cash Flow
N/A
Earnings
22.67
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
446M
Current Ratio
0.74
Current Revenue Per Employee
1122945.60
Dividends Per Share - Security
0.00
EBITDA
137B
Float
N/A
Float - Current
N/A
Gross Income Margin
84.80
Revenue To Assets
25.89
Shares Held By Institutions
133B
Shares Outstanding - Current
4.44B
Total Liabilities
322B
Total Volume MTD
N/A
Value
1
Gain YTD
-3.046
View a ticker or compare two or three
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com